# US 2009/0269367 A1 · Methods and compounds for mitigating pathogenic outbreaks using replikin count cycles

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2009/0269367 A1
- Document ID: US20090269367A1
- Status: Published application
- Kind: A1
- Application number: 12/429,044
- Filed: 2009-04-23
- Published: 2009-10-29
- Earliest claimed: 2008-04-23
- Inventors: Samuel BOGOCH; Elenore S. BOGOCH; Samuel Winston BOGOCH; Anne Elenore BORSANYI
- Web page: https://patentgrep.com/patent/US20090269367A1

## CPC

- C07K 14/44: from protozoa
- A61K 39/12: Viral antigens
- A61K 39/145: Orthomyxoviridae, e.g. influenza virus
- C07K 14/005: from viruses
- C07K 14/72: for hormones {(for neuromediators C07K14/70571)}
- A61K 39/00: Medicinal preparations containing antigens or antibodies (materials for immunoassay G01N33/53)
- A61K 2039/542: {oral/gastrointestinal}
- A61K 2039/543: {intranasal}
- A61K 2039/544: {to the airways}
- A61K 2039/552: {Veterinary vaccine}
- C12N 2710/18022: New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C12N 2760/16122: New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C12N 2760/16134: Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- C12N 2770/24122: New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C12N 2770/32122: New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)

## Abstract

The present invention provides methods of predicting increases in pathogenic virulence, morbidity, and/or mortality or expansion in pathogen populations within regions or into new regions by identifying cycles or ratios of increasing concentrations of a family of small peptides expressed in pathogens and provides compounds comprising the small peptides for treatment and prevention of pathogenic outbreaks.

## Claims

### Claim 1

A method of predicting an expansion of a population of a first pathogen comprising:
identifying at least one cycle of Replikin concentration in isolates of the first pathogen; and
predicting that an expansion of the population of the first pathogen will take place after the occurrence of at least one rising portion of the at least one cycle of Replikin concentration, wherein the at least one cycle is cycle A.

### Claim 2 (depends on 1)

The method of claim 1, wherein the at least one rising portion comprises a peak and wherein said expansion of the population of the first pathogen is predicted after the occurrence of the peak.

### Claim 3 (depends on 1)

The method of claim 1, wherein said at least one rising portion comprises at least a first rising portion and a second rising portion, wherein said first rising portion occurs prior in time to said second rising portion.

### Claim 4 (depends on 1)

The method of claim 1, wherein said at least one rising portion comprises at least rising portion A′, rising portion B′ and rising portion C′.

### Claim 5 (depends on 4)

The method of claim 4, wherein said rising portion B′ comprises a peak B and said rising portion A′ comprises a peak A, and wherein the peak B of rising portion B′ has a greater Replikin concentration than the peak A of rising portion A′.

### Claim 6

A method of predicting an expansion of a population of a pathogen comprising:
identifying at least one cycle of the Replikin concentration of a plurality of isolates of the pathogen or of a related pathogen,
identifying a first peak in the Replikin concentration of a plurality of isolates of said pathogen within the at least one identified cycle at a first time point or time period, and
predicting that an expansion of the population of a pathogen of the same species that is isolated at a second time point or time period will occur subsequent to the first time point or time period.

### Claim 7 (depends on 1)

The method of claim 1, wherein said first pathogen is a malarial trypanosome, a West Nile virus, a foot and mouth disease virus, or an influenza virus.

### Claim 8 (depends on 1)

The method of claim 1, wherein said first pathogen is an H5N1 strain of influenza virus.

### Claim 9 (depends on 1)

The method of claim 1, further comprising:
identifying at least one other cycle of Replikin concentration in isolates of at least one other strain of pathogen, wherein the at least one other cycle is cycle B, and wherein cycle B shares synchrony with cycle A; and
predicting that an expansion of the population of the first pathogen will occur after the occurrence of the at least one rising portion in cycle A, wherein the at least one rising portion in cycle A corresponds to a rising portion in cycle B.

### Claim 10 (depends on 9)

The method of claim 9, wherein said first pathogen is a strain of influenza virus and wherein said at least one other strain of pathogen is a different strain of influenza virus.

### Claim 11 (depends on 9)

The method of claim 9, wherein said first pathogen is an H5N1 strain of influenza virus and said at least one other strain of pathogen is an H9N2 strain of influenza virus.

### Claim 12 (depends on 2)

The method of claim 2, wherein said expansion of the population of the first pathogen is predicted within three years after said peak.

### Claim 13 (depends on 2)

The method of claim 2, wherein said expansion of the population of the first pathogen is predicted within one year after said peak.

### Claim 14 (depends on 2)

The method of claim 2, wherein said expansion of the population of the first pathogen is predicted after a next virulence season of the pathogen.

### Claim 15 (depends on 1)

An isolated or synthesized protein, protein fragment, or peptide comprising a Replikin peptide or a Replikin Peak Gene of a pathogen, wherein said pathogen is predicted to have an expansion of the population of the pathogen in accordance with the method of claim 1.

### Claim 16 (depends on 15)

The isolated or synthesized protein, protein fragment, or peptide of claim 15 consisting of one or more Replikin peptides and/or one or more Replikin Peak Genes.

### Claim 17 (depends on 16)

The isolated or synthesized protein, protein fragment, or peptide of claim 16, wherein said one or more Replikin peptides are conserved during the at least one cycle in Replikin concentration at least two successive time points or time periods in the at least one cycle.

### Claim 18 (depends on 17)

The isolated or synthesized protein, protein fragment, or peptide of claim 17 comprising at least one of peptide of HAQDILEKEHNGKLCSLKGVRPLILK (SEQ ID NO: 1), KEHNGKLCSLKGVRPLILK (SEQ ID NO: 2), KKNNAYPTIKRTYNNTNVEDLLIIWGIHH (SEQ ID NO: 3), HHSNEQGSGYAADKESTQKAIDGITNK (SEQ ID NO: 4), HDSNVKNLYDKVRLQLRDNAK (SEQ ID NO: 5), KVRLQLRDNAKELGNGCFEFYH (SEQ ID NO: 6), KDVMESMDKEEMEITTH (SEQ ID NO: 7), HFQRKRRVRDNMTKK (SEQ ID NO: 8), KKWSHKRTIGKKKQRLNK (SEQ ID NO: 9), HKRTIGKKKQRLNK (SEQ ID NO: 10), HEGIQAGVDRFYRTCKLVGINMSKKK (SEQ ID NO: 11); or HSWIPKRNRSILNTSQRGILEDEQMYQKCCNLFEK (SEQ ID NO: 12).

### Claim 19 (depends on 15)

An immunogenic composition comprising the isolated or synthesized protein, protein fragment, or peptide of claim 15.

### Claim 20 (depends on 19)

The immunogenic composition of claim 19, wherein said isolated or synthesized protein, protein fragment, or peptide consists of a Replikin peptide or a Replikin Peak Gene.

### Claim 21 (depends on 20)

The immunogenic composition of claim 20, wherein said Replikin peptide or said Replikin Peak Gene are conserved during at least one of the at least one cycle in Replikin concentration at least two successive time points or time periods in the at least one of the at least one cycle.

### Claim 22 (depends on 1)

A method of preventing, mitigating, or treating an outbreak of a first pathogen predicted to have an expansion of population comprising:
predicting the expansion of the population of the first pathogen in accordance with the method of claim 1; and
administering to an animal or patient a compound comprising an isolated or synthesized portion of the structure or genome of the first pathogen to mitigate, prevent, or treat the predicted outbreak of the first pathogen.

### Claim 23 (depends on 1)

A method of making a vaccine comprising:
predicting the expansion of the population of the first pathogen in accordance with claim 1; and
identifying a portion of the structure or genome of said first pathogen to be comprised in a vaccine.

### Claim 24 (depends on 1)

A computer readable medium having stored thereon instructions which, when executed, cause a processor to perform the method of predicting the expansion of the population of the first pathogen of claim 1.

### Claim 25 (depends on 1, 24)

The computer readable medium of claim 24 wherein said method of predicting an expansion of the population of the first pathogen of claim 1 further comprises outputting the prediction to a display, user, researcher, or other machine or person.

### Claim 26 (depends on 24)

The computer readable medium of claim 24 further comprising instructions stored thereon which, when executed, cause a processor to identify to a display, user, researcher, or other machine or person, at least one Replikin peptide of said first pathogen that is conserved in said first pathogen.

### Claim 27

A method of predicting an expansion of a strain of pathogen comprising:
determining a mean Replikin Count and a standard deviation of said mean Replikin Count for a plurality of isolates of a strain of pathogen for a first time period in a first geographic region;
determining a Replikin Count of at least one isolate of the same or a related strain of pathogen from a second time period and/or second geographic region, wherein said second time period is different from said first time period and/or said second geographic region is different from said first geographic region, and wherein the second time period is not necessarily after the first time period; and
predicting an expansion of said strain of pathogen isolated in said second time period and/or said second geographic region if the Replikin Count of said at least one isolate is greater than one standard deviation of the mean of the Replikin Count of the plurality of isolates isolated in said first time period and in said first geographic region.

### Claim 28 (depends on 27)

The method of claim 27, wherein the at least one isolate of the same strain of pathogen from a second time period and/or second geographic region is a plurality of isolates from said second time period and/or said second geographic region, and the Replikin Count of each isolate of the plurality of isolates from said second time period and/or second geographic region is compared separately to said one standard deviation of said mean Replikin Count.

### Claim 29 (depends on 28)

The method of claim 28, wherein the expansion of said strain of pathogen isolated in said second time period and/or said second geographic region is predicted if the number of Replikin Counts of said plurality of isolates from said second period and/or said second geographic region that is greater than one standard deviation of the mean of the Replikin Count of the plurality of isolates isolated in said first time period in said first geographic region, is greater than the number of Replikin Counts of said plurality of isolates from said second time period and/or said second geographic region that is less than said one standard deviation of the mean.

### Claim 30 (depends on 27)

The method of claim 27, wherein said pathogen is an influenza virus, a malarial trypanosome, a West Nile virus, or a foot and mouth disease virus.

### Claim 31 (depends on 27)

The method of claim 27, wherein said first time period is one year and said first geographic region is a country.

### Claim 32 (depends on 31)

The method of claim 31, wherein said second time period is one year and said second geographic region is a country.

### Claim 33 (depends on 27)

A method of preventing, mitigating, or treating an outbreak of a pathogen comprising predicting an expansion of a strain of pathogen in accordance with claim 27 and administering to an animal or a patient a compound comprising an isolated or synthesized portion of the structure or genome of the at least one isolate of pathogen to prevent or treat the outbreak of the pathogen.

### Claim 34 (depends on 1)

The method of claim 1, wherein said method is performed by a computer.

### Claim 35 (depends on 27)

The method of claim 27, wherein said method is performed by a computer.

### Claim 36 (depends on 6)

The method of claim 6, wherein said method is performed by a computer.

### Claim 37 (depends on 28)

The method of claim 28, wherein said method is performed by a computer.

### Claim 38 (depends on 6)

The method of claim 6, wherein said pathogen is a malarial trypanosome, a West Nile virus, a foot and mouth disease virus, or an influenza virus.

### Claim 39 (depends on 6)

The method of claim 6, wherein said pathogen is an H5N1 strain of influenza virus.

### Claim 40

A quantitative cyclic structure comprising Replikin peptide concentrations identified in a strain of microorganism through time, wherein said cyclic structure correlates in time with the expansion and/or contraction of a population of said strain of microorganism, the infectivity of said strain of microorganism, and/or the lethality of said strain of microorganism in its host.
